Read more at CNBC.
Eli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials
Date: |
Sort by
Filter
Date
Items per page
-
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
The world's most valuable drugmaker hiked its full-year sales and profit guidance, despite missing lighter-than-expected first-quarter revenue.CNBC - Business -
Barbra Streisand asks Melissa McCarthy about Ozempic, sparking debate on weight
Streisand's comment on an Instagram photo of McCarthy had people talking.ABC News - Top stories -
New Calamos ETF promises ‘100% downside protection.’ Here's how it works
“There’s no tricks. There’s no magic. This is the secret sauce,” Calamos Investments’ Matt Kaufman said.CNBC - Business -
7 Best Sleeping Pads (2024): For Camping, Backpacking, and Travel
Whether you’re snoozing in a campground or schlepping up to an alpine valley, these are the best pads we’ve found for resting your weary bones.Wired - Tech -
Conservative states challenge federal rule on treatment of transgender students
Republican state attorneys general are challenging a new federal regulation that mandates protections for transgender students at schoolsABC News - Health -
Schemes targeting seniors account for $3.4 billion in reported losses, FBI says
Reports of elder fraud crimes increased by 14% in 2023, according to a new federal report.CBS News - Politics -
Ex-Tesla worker says he lost job despite sacrifices, including sleeping in car
One ex-Tesla employee's post about the shock of losing his job amid a round of layoffs is sparking a workplace debate.CBS News - Top stories -
'Vampire facials' were linked to cases of HIV. Here's what to know about the beauty treatment
The Centers for Disease Control and Prevention issued a report last week that documented the first instances of HIV transmissions contracted through unsterile injections used while receiving “vampire facials,” cosmetic procedures involving ...ABC News - Tech -
Cannabis stocks rally after report that DEA will reclassify drug as less dangerous
Cannabis stocks were up sharply on Tuesday on a report by the Associated Press that the U.S. Drug Enforcement Administration is poised to propose moving cannabis to a Schedule III controlled substance.MarketWatch - Business -
Biden Administration Aims to Reclassify Marijuana as Less Dangerous Drug
The move would reshape the multibillion-dollar industry.The Wall Street Journal - World - Joe Biden
More from CNBC
-
Amazon cost cuts drive operating margin into double digits for first time
Amazon's operating margin jumped past 10%, topping a prior high of 8.2% in 2021.CNBC - Business -
AMD says it will sell $4 billion in AI chips this year; stock drops on in-line forecast
AMD sells AI chips that compete with Nvidia, but it makes most of its money from PC chips.CNBC - Business -
Starbucks shares sink 12% as coffee chain slashes 2024 forecast amid same-store sales drag
Across all regions, Starbucks reported shrinking same-store sales and falling traffic.CNBC - Business -
DJT: Trump receives 36 million shares of Trump Media worth $1.8 billion as earnout bonus
The shares were part of a contractual "earnout bonus" that Trump's eponymous media company agreed to shortly before it went public in March.CNBC - Business - Donald Trump -
Pinterest shares soar 18% on earnings beat, strong revenue growth
Shares of Pinterest popped in extended trading Tuesday after the company reported first-quarter results.CNBC - Business